0001179110-21-002596.txt : 20210302 0001179110-21-002596.hdr.sgml : 20210302 20210302202749 ACCESSION NUMBER: 0001179110-21-002596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GONZALEZ RICHARD A CENTRAL INDEX KEY: 0001239127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 21706574 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2021-02-28 0 0001551152 AbbVie Inc. ABBV 0001239127 GONZALEZ RICHARD A 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 1 1 0 0 Chairman of the Board and CEO Common Stock, $0.01 par value 2021-02-26 5 G 0 E 3325 0 D 450981 D Common Stock, $0.01 par value 2021-02-28 4 F 0 74384 107.74 D 376597 D Common Stock, $0.01 par value 2021-03-02 4 M 0 170113 54.86 A 546710 D Common Stock, $0.01 par value 2021-03-01 4 S 0 169482 108.6087 D 377228 D Common Stock, $0.01 par value 2021-03-01 4 S 0 631 109.325 D 376597 D Common Stock, $0.01 par value 17615 I By Spouse Common Stock, $0.01 par value 5900 I By Step-daughter Common Stock, $0.01 par value 5900 I By Step-son Option (Right To Buy) 000 2021-03-02 4 M 0 170113 54.86 D 2017-02-18 2026-02-17 Common Stock 170113 0 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.207 to $109.20 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.25 to $109.38 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person disclaims beneficial ownership of these securities. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Richard A. Gonzalez 2021-03-02